Skip to main content
. 2021 Jun 10;117(5):954–964. [Article in Portuguese] doi: 10.36660/abc.20200920

Table 2. – Demographic data e clinical outcomes according to the presence or absence of echocardiographic abnormalities.

Demographic data, treatment strategies and clinical outcomes Echocardiographic abnormalities
Present ( n = 23) Absent ( n = 25) p
Age (years) 7.8 (0.1-16.4) 6.4 (0-18.6) 0.87
Sex (male) 11 (47.8%) 16 (64%) 0.38
MIS-c according to WHO criteria 19 (82.6%) 1 (4%) <0.0001
Pediatric Intensive Care Unit 15 (65.2%) 5 (20%) 0.003
Multiple organ dysfunction syndrome 8 (34.8%) 0 (0%) 0.0013
Respiratory system 6 (26%) 0 (0%)  
Cardiovascular system 6 (26%) 0 (0%)  
Renal system 5 (21.7%) 0 (0%)  
Hepatic system 2 (8.7%) 0 (0%)  
Neurological system 4 (17.4%) 0 (0%)  
Hematological system 4 (17.4%) 0 (0%)  
Ventilatory support 15 (65.2%) 7 (28%) 0.02
Oxygen by nasal catheter 8 (34.8%) 3 (12%)  
Venturi mask 3 (13%) 1 (4%)  
Non-rebreather mask 0 (0%) 1 (4%)  
High-flow oxygen therapy 6 (26%) 1 (4%)  
Noninvasive ventilation 5 (21.7%) 1 (4%)  
Conventional Mechanical ventilation 10 (43.5%) 3 (12%)  
High-frequency ventilation 1 (4.3%) 0 (0%)  
Vasoactive drug support 10 (43.5%) 1 (4%) 0.0015
Epinephrine 4 (17.4%) 0 (0%)  
Norepinephrine 10 (43.5%) 1 (4%)  
Vasopressin 2 (8.7%) 0 (0%)  
Milrinone 5 (21.7%) 1 (4%)  
Dobutamine 3 (13%) 0 (0%)  
Renal replacement therapy 5 (21.7%) 2 (8%) 0.23
Peritoneal dialysis 0 (0%) 2 (8%)  
Conventional hemodialysis 1(4.3%) 0 (0%)  
Sustained low-efficiency dialysis 1 (4.3%) 0 (0%)  
Continuous hemodialysis 3 (13%) 0 (0%)  
IV Immunoglobulin 14 (60.8%) 0 (0%) <0.0001
Corticosteroids 4 (17.4%) 0 (0%) 0.04
Acetylsalicylic acid 9 (39%) 0 (0%) 0.0005
Low molecular weight heparin 9 (39.1%) 1 (4%) 0.0038
Length of stay (days) 23 (2-92) 8.3 (2-26) 0.0074
Deaths 6 (26%) 1 (4%) 0.04

Values are expressed as n (%) or as median (range). Fisher exact test was used to compare categorical data. Mann-Whitney U test was used to compare non-normally distributed continuous variables.